Audit:
Hit List: Beware of OIG's Ongoing Audit Activities
Published on Thu Nov 26, 2015
Prescription drugs are a hot topic under Medicare Part B, too. Just because the HHS Office of Inspector General (OIG) has a slew of new initiatives in its Fiscal Year (FY) 2016 Work Plan doesn’t mean that the watchdog is slowing down or stopping its ongoing investigations. And for some providers, the recurring reviews will pose greater threats than the [...]